Patents-Review.com
🔗 Permalink
Assignee profile:

WATSON PHARMACEUTICALS, INC.

City:

Corona, California

Country:

United States

Published Applications:

12

Last publication date:

2012-07-19

Patent Grants:

11

Last grant date:

2013-12-03

Top Inventors for applications by WATSON PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to WATSON PHARMACEUTICALS, INC.:

Recent patent applications by WATSON PHARMACEUTICALS, INC.

WATSON PHARMACEUTICALS, INC. based in Corona, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-07-19
US20120184591A1
Human necessities

METHODS FOR TREATING PROSTATITIS

 #2 | 2012-05-31 ✅ Patent 8,597,683 granted on 2013-12-03
US20120135079A1
Human necessities

Modified release tranexamic acid formulation

 #3 | 2011-10-27 ✅ Patent 8,470,368 granted on 2013-06-25
US20110262538A1
Human necessities

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

 #4 | 2011-06-14 ✅ Patent 7,959,946 granted on 2011-06-14
US10777542
-

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

 #5 | 2010-12-16 ✅ Patent 8,309,125 granted on 2012-11-13
US20100316708A1
Human necessities

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

 #6 | 2010-08-31 ✅ Patent 7,785,627 granted on 2010-08-31
US10664803
-

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

 #7 | 2008-03-04 ✅ Patent 7,338,667 granted on 2008-03-04
US10342222
-

Pharmaceutical formulation

 #8 | 2007-09-06 ✅ Patent 8,309,104 granted on 2012-11-13
US20070207203A1
Human necessities

Oral controlled release formulation for sedative and hypnotic agents

 #9 | 2007-03-06 ✅ Patent 7,186,706 granted on 2007-03-06
US10278033
-

Administration of non-oral androgenic steroids to women

 #10 | 2005-11-10 ✅ Patent 8,084,058 granted on 2011-12-27
US20050249809A1
Human necessities

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

 #11 | 2005-10-13 ✅ Patent 7,179,483 granted on 2007-02-20
US20050226898A1
Human necessities

Compositions and methods for transdermal oxybutynin therapy

 #12 | 2005-03-15 ✅ Patent 6,866,865 granted on 2005-03-15
US10370746
-

Dosage forms and methods for oral delivery of progesterone

Also check out Watson Pharmaceuticals, Inc.'s (Corona, United States) applicant profile with 1 patent applications submitted.

AssigneeID:

183631 ⎘